UNIPHARMA ApS: Financial statements 2020
CVR: 78881917
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
UNIPHARMA ApS (CVR 78881917) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK -5,000 and a net result of DKK -5,000 compared with DKK -5,000 the year before. Equity in the 2020 report amounted to DKK 61,735. The solvency ratio was 34.2%.
- Revenue
- DKK -5,000
- Gross Profit
- DKK -5,000
- Profit/Loss
- DKK -5,000
- Equity
- DKK 61,735
- Total Assets
- DKK 180,490
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | -5 t. | -5 t. | -5 t. | 62 t. | - |
| 2019 | -5 t. | -5 t. | -5 t. | 67 t. | - |
| 2018 | -10 t. | -10 t. | -10 t. | 72 t. | - |
| 2017 | -9 t. | -9 t. | -9 t. | 73 t. | - |
| 2016 | - | -11 t. | -11 t. | 82 t. | - |
Official annual report
How creditworthy is UNIPHARMA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
UNIPHARMA ApS has published its annual report for 2019. Revenue came to DKK -5,000, and the net result was DKK -5,000.
About UNIPHARMA ApS
UNIPHARMA ApS is a Danish company of the type Anpartsselskab based in København K, founded in 1985. The company is under bankruptcy. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company is owned by Ebba Dorrit Reumert. According to the 2023 annual report, the company had an average of 0 employees. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2024 report amounted to DKK -124,033.